Last reviewed · How we verify
NCT06691997
The Impact of Glycemic Control on Rheumatoid Arthritis Disease Activity on Diabetic Patients
trial in Rheumatoid Arthritis (RA in 100 participants. Not yet recruiting.
14 November 2026
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 12 December 2024 |
| Primary completion | 14 November 2026 |
| Estimated completion | 1 June 2027 |
| Sites | 1 location across Egypt |
Conditions studied
- Rheumatoid Arthritis (RA — all drugs for Rheumatoid Arthritis (RA →
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Assiut University
Who can join
Adults 18 to 65, any sex, with Rheumatoid Arthritis (RA or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The incidence of DM is unclear in RA but most prior data suggest that DM or insulin resistance in RA has risen because of activation of the immune system and/or RA therapy . Besides, RA causes joints to become stiff, swollen, and agonizing. As a result, the patient may not want to exercise or move. One study found that 42% of people with RA are not physically active. the aim of this study is To evaluate the glycemic status among RA patients with Type 2 diabetes and its association with disease activity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06691997
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rheumatoid Arthritis (RA
Currently open trials in the same condition.
- NCT07401732 — Dysphagia in Rheumatoid Arthritis · recruiting
- NCT07034196 — Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Car · NA · recruiting
- NCT06994143 — A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT06838884 — An Alternative Assessment in Patients with Rheumatoid Arthritis: 6 Minute Step Test · NA · recruiting
- NCT07359326 — The Effect of Cold Application in Patients With Rheumatoid Arthritis · NA · active not recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06691997 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 18 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06691997.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing